Learn More
CD44 Mouse anti-Human, BUV395, Clone: G44-26 (also known as C26), BD Optibuild™
Shop All BD Biosciences ProductsDescription
The G44-26 monoclonal antibody specifically binds to the 80-95 kDa, glycosylated type I transmembrane protein, also known as phagocytic glycoprotein-1 (Pgp-1). CD44 is the receptor for hyaluronic acid. CD44 is expressed on leucocytes, erythrocytes, epithelial cells and weakly on platelets. CD44 is also called extracellular matrix receptor type III and has functional roles in cell migration, lymphocyte homing and adhesion during hematopoiesis and lymphocyte activation. This antibody is suitable for staining formalin-fixed, paraffin-embedded tissue sections using citrate buffer pretreatment. This antibody recognizes the epitope 1 of CD44 antigen according to the HLDA workshop studies.
The antibody was conjugated to BD Horizon™ BUV395 which is part of the BD Horizon Brilliant™ Ultraviolet family of dyes. This dye has been exclusively developed by BD Biosciences to have minimal spillover into other detectors, making it an optimal choice for multicolor flow cytometry. With an Ex Max at 348nm and an Em Max at 395nm, BD Horizon BUV395 can be excited with a 355nm laser and detected with a 379/28 filter.
Specifications
Specifications
| Antigen | CD44 |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | G44-26 (also known as C26) |
| Concentration | 0.2mg/mL |
| Conjugate | Brilliant Ultraviolet 395 |
| Description | Phagocytic glycoprotein 1; Pgp-1; H-CAM; Hermes; ECMR III; HUTCH-1 |
| Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
| Host Species | Mouse |
| Purification Method | Affinity Purified |
| Show More |
Safety and Handling
For Research Use Only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.